Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee.
Semin Respir Crit Care Med. 2020 Apr;41(2):229-237. doi: 10.1055/s-0040-1708054. Epub 2020 Apr 12.
The interstitial lung diseases (ILDs) are a group of progressive disorders characterized by chronic inflammation and/or fibrosis in the lung. While some ILDs can be linked to specific environmental causes (i.e., asbestosis, silicosis), in many individuals, no culprit exposure can be identified; these patients are deemed to have "idiopathic interstitial pneumonia" (IIP). Family history is now recognized as the strongest risk factor for IIP, and IIP cases that run in families comprise a syndrome termed "familial interstitial pneumonia" (FIP). Mutations in more than 10 different genes have been implicated as responsible for disease in FIP families. Diverse ILD clinical phenotypes can be seen within a family, and available evidence suggests underlying genetic risk is the primary determinant of disease outcomes. Together, these FIP studies have provided unique insights into the pathobiology of ILDs, and brought focus on the unique issues that arise in the care of patients with FIP.
间质性肺疾病(ILDs)是一组以肺部慢性炎症和/或纤维化为特征的进行性疾病。虽然某些ILDs 可与特定的环境原因相关(例如石棉肺、矽肺),但在许多患者中,无法确定致病因素;这些患者被认为患有“特发性间质性肺炎”(IIP)。家族史现在被认为是 IIP 的最强危险因素,在有家族史的 IIP 病例中,有一种综合征称为“家族性间质性肺炎”(FIP)。已有 10 多种不同基因的突变被认为与 FIP 家族的疾病有关。在一个家族中可以看到不同的ILD 临床表型,现有证据表明,潜在的遗传风险是疾病结局的主要决定因素。总之,这些 FIP 研究为 ILD 的发病机制提供了独特的见解,并关注 FIP 患者护理中出现的独特问题。